微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 34.16% | -44.76% | 11.78% | 1/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 30.56% | -36.78% | 8.6% | 1/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 28.14% | -51.64% | -28.83% | 1/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 39.54% | 166.39% | -36.06% | 1/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 61.84% | 88.14% | 27.93% | 1/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 48.34% | -6.46% | -16.93% | 1/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 58.19% | 42.17% | 197.7% | 1/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -59.56% | 75.13% | -281.2% | 48/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 32.87% | 117.92% | -36.4% | 5/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 51.68% | 136.69% | 26.26% | 1/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 40.93% | 923.25% | 117.09% | 1/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -239.51% | -372.03% | -30.61% | 49/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | -183.38% | -1074.01% | -30.19% | 39/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -140.86% | -716.11% | -3621.5% | 48/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 4% | 144.35% | 107.88% | 10/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -50.74% | -72.64% | -224.84% | 50/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -15.62% | 9.45% | 9.5% | 32/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -17.26% | -54.8% | -91.35% | 38/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -9.02% | -206.8% | 69.31% | 30/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -29.39% | -401.54% | -70.38% | 45/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | -17.25% | -1171.43% | -54.71% | 30/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | -11.15% | -1181.61% | -279.25% | 32/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | -2.94% | -301.37% | 49.83% | 29/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -5.86% | -161.95% | -463.98% | 41/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 1.61% | -87.96% | 285.06% | 22/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | -0.87% | -110.39% | -159.59% | 30/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.46% | -66.89% | -84.57% | 15/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 9.46% | -50.83% | -29.24% | 20/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 13.37% | -25.43% | 59.74% | 7/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 8.37% | 2.95% | 89.8% | 9/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 4.41% | 38.24% | -77.08% | 4/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 19.24% | 78.48% | 7.31% | 10/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 17.93% | 74.76% | 120.54% | 4/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 8.13% | 438.41% | 154.86% | 9/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 3.19% | 1495% | -70.41% | 6/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 10.78% | 156.56% | 5.07% | 15/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 10.26% | 230.2% | 579.47% | 6/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 1.51% | 118.64% | 655% | 14/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 0.2% | 103.85% | 101.05% | 13/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |